TGA Approval

XOLAIR omalizumab (rch) 150 mg solution for injection pre-filled pen (429511)

ARTG ID

429511

ARTG Name

XOLAIR omalizumab (rch) 150 mg solution for injection pre-filled pen

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

September 4, 2024

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-05307-3

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2009-PI-00304-3

Ingredient Name

Omalizumab

Empowering clinical research with data-driven insights and AI-powered tools.

XOLAIR omalizumab (rch) 150 mg solution for injection pre-filled pen (429511) - TGA 批准文号 | MedPath